Disease states can profoundly alter drug pharmacokinetics, affecting drug therapy outcomes. This book investigates how various pathological conditions, such as cardiovascular, hepatic, renal, and gastrointestinal diseases, influence drug absorption, distribution, metabolism, and excretion. It discusses the physiological changes associated with these diseases and their impact on drug kinetics, providing strategies for dose adjustment and therapeutic optimization. Aimed at clinicians, pharmacists, and pharmacologists, the book offers a comprehensive understanding of the interplay between disease states and drug pharmacokinetics to enhance patient care.
Chloe Moreno is a distinguished dermatologist specializing in the influence of disease states on drug pharmacokinetics, focusing on how various health conditions affect the absorption, distribution, metabolism, and excretion of dermatological medications. Her research explores the pharmacokinetic alterations caused by diseases such as liver dysfunction, kidney disease, and chronic inflammatory conditions, impacting the efficacy and safety of skin treatments. Chloe has published extensively on personalized pharmacological approaches that consider underlying disease states to optimize dermatological therapy outcomes. She has developed comprehensive protocols that assess and adjust pharmacokinetic factors based on patients' disease profiles. She also provides comprehensive guidelines and insights for clinicians to assess and adjust pharmacokinetic factors based on patients' disease profiles, promoting safe and effective dermatological care through tailored pharmacological strategies.